]>
IRCT20191217045767N1 IRCT 2020-10-11 Mashhad University of Medical Sciences Effects of statin on lipid profile in STEMI patients Comparison of the effects of high-dose atorvastatin and high-dose rosuvastatin on lipid profile in STEMI patients 2019-12-21 anticipated 90 Complete https://irct.ir/trial/46109 interventional Randomization: Not randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment. 3 hyperlipidemia-acute myocardial infarction. Intervention 1: Intervention group: Atorvastatin 80 mg daily. Intervention 2: Intervention group: Rosuvastatin 40 mg daily. Yes - There is a plan to make this available What will be shared: All potential data can be shared after unidentifiable people When: Start of access period 6 months after printing results To whom: Researchers working in academic and scientific institutions Conditions: For further research and studies Where to obtain: Keep in touch with alirezasabour8895@yahoo.co How to obtain: After the request has been submitted by the applicant, it is first reviewed and responded to via email Comments:
public Ali Eshraqi
Third Floor- Plaque23-Sayyad St. Shirazi4-Vakil Abad Boulevard
Mashhad Iran (Islamic Republic of) 9188993547 +98 51 3893 5179 alirezasabour8895@yahoo.com Mashhad University of Medical Sciences scientific Ali Eshraqi
Third Floor-Plaque23- Sayyad St. Shirazi4-Vakil Abad Boulevard
Mashhad Iran (Islamic Republic of) 9188993547 +98 51 3893 5179 alirezasabour8895@yahoo.com Mashhad University of Medical Sciences Iran (Islamic Republic of) Iran (Islamic Republic of) STEMI patients (for the first time) who receive Primary PCI within the first 6 hours Age range 18 to 65 years Consent to enter the research project and complete the informed consent form 18 years 65 years Both Previous history of statin use Patients with a previous history of cardiac surgery Patients who subsequently undergo PCI have been nominated for CABG 121 Acute myocardial infarction Treatment - Drugs Treatment - Drugs Intervention group: Atorvastatin 80 mg daily Intervention group: Rosuvastatin 40 mg daily Lipid Profile (LDL, HDL, Total Cholesterol, Triglyceride). Timepoint: At baseline and one month later. Method of measurement: blood test. Mashhad University of Medical Sciences Approved 2019-08-04 Ethics committee of Mashhad University of Medical Sciences Third Floor, No. 23, 4 Sayyad Shirazi Street, Vakil Abad Boulevard Mashhad Razavi Khorasan Iran (Islamic Republic of)